drugset
drugset / Trial / NCT03851939

The Efficacy of Transarterial Chemoinfusion (TAI) Combine Toripalimab in Advanced Hepatocellular Carcinoma (HCC)

NCT03851939 ↗

Phase 2 Unknown 65 enrolled Sun Yat-sen University
NaSingle-groupOpen-labelTreatment

Summary

To evaluate the efficacy of TAI combine toripalimab in advanced HCC.

Timeline

Start
2019-02-26
Primary completion
2020-03-01
Completion
2021-03-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Toripalimab Monoclonal antibody — —

Indications

hepatocellular carcinoma